Predicting the clinical outcome of HbE beta thal is very difficult. The IVS 1-5 (G-c) gene is known to be present in beta thal major, but its presentation when combined with HbE is quite variable, as you have seen with your child. He may well stay the same into adulthood, needing only occasional transfusions. HbE beta thal responds well to even small increases in fetal Hb. Diet and nutrition are important and it would be worthwhile to try wheatgrass, either in juice form or as tablets. Tablets are much more palatable. There is also an adaptation of unknown origin in HbE beta thals, that allows many to avoid transfusions even at lower Hb levels, where transfusion would normally begin. In these cases, transfusion should not begin unless the child is showing signs of severe anemia. If the child is active, healthy and growing, transfusions may not be the proper course in HbE beta thal, so observation is key. Any further children have the same risk of this combination, 25%. Even then, other genetic factors may play a role, so there is no assumption that the condition would manifest the same in two children from the same parents.